Sonim regains Nasdaq minimum bid price compliance; bid price above $1.00 since Oct 27

DNA X, Inc.

Nasdaq Staff confirmed closing bid price at $1.00+ from Oct 27 to Nov 11, 2025.
Regained compliance with Nasdaq Listing Rule 5550(a)(2); delisting matter closed.
No further extension or conditions; Sonim common stock remains listed on Nasdaq.

item 8.01

DNA X, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-022286

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.